Please login to the form below

Not currently logged in
Email:
Password:

Sosei appoints CFO

Andrew Oakley joins the Tokyo-based pharma firm

Sosei Andrew OakleyAndrew Oakley has joined Tokyo-based pharmaceutical firm Sosei as chief financial officer, succeeding Hidetoshi Torami.

Oakley brings a varied corporate finance career to the firm, most recently having served as chief financial officer of Vectura Group.

Prior to this, he held the same title at several other biotech companies, including Actelion and Novimmune.

Peter Bains, chief executive officer of Sosei, said: “Andrew brings a wealth of global corporate finance experience, expertise and leadership with a particularly strong focus in the biotechnology sector.

“I am delighted to welcome him to Sosei as our new chief financial officer and look forward to working with Andrew in the coming years as we seek to build Sosei into a global presence.”

31st January 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics